Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sanson

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of Neuro-Oncology|August 20, 2013
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapyF Ducray, G Kaloshi, C Houillier, et al.
Neuropathology and Applied Neurobiology|March 17, 2009
Epidermal growth factor receptor extracellular domain mutations in primary glioblastomaA Idbaih, J Aimard, B Boisselier, et al.
Acta Oncologica (Stockholm, Sweden)|December 16, 2017
Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disabilityM J Ibañez-Juliá, G Berzero, G Reyes-Botero, et al.
Revue Neurologique|July 23, 2004
[Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas]G Noël, Chiraz N Ben Ammar, L Feuvret, et al.
Neurology|December 30, 2004
Correlations between molecular profile and radiologic pattern in oligodendroglial tumorsF Laigle-Donadey, N Martin-Duverneuil, J Lejeune, et al.
Neurology|July 28, 2004
Initial chemotherapy in gliomatosis cerebriM Sanson, S Cartalat-Carel, S Taillibert, et al.
Neurology|April 30, 2010
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2M Labussière, A Idbaih, X-W Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletionsK Hoang-Xuan, L Capelle, M Kujas, et al.
British Journal of Cancer|October 15, 2014
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlationsM Labussière, A L Di Stefano, V Gleize, et al.
Neurology|May 6, 2009
Bevacizumab and irinotecan for recurrent oligodendroglial tumorsS Taillibert, L A Vincent, B Granger, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Neuro-Oncology|August 20, 2013
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapyF Ducray, G Kaloshi, C Houillier, et al.
Neuropathology and Applied Neurobiology|March 17, 2009
Epidermal growth factor receptor extracellular domain mutations in primary glioblastomaA Idbaih, J Aimard, B Boisselier, et al.
Acta Oncologica (Stockholm, Sweden)|December 16, 2017
Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disabilityM J Ibañez-Juliá, G Berzero, G Reyes-Botero, et al.
Revue Neurologique|July 23, 2004
[Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas]G Noël, Chiraz N Ben Ammar, L Feuvret, et al.
Neurology|December 30, 2004
Correlations between molecular profile and radiologic pattern in oligodendroglial tumorsF Laigle-Donadey, N Martin-Duverneuil, J Lejeune, et al.
Neurology|July 28, 2004
Initial chemotherapy in gliomatosis cerebriM Sanson, S Cartalat-Carel, S Taillibert, et al.
Neurology|April 30, 2010
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2M Labussière, A Idbaih, X-W Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletionsK Hoang-Xuan, L Capelle, M Kujas, et al.
British Journal of Cancer|October 15, 2014
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlationsM Labussière, A L Di Stefano, V Gleize, et al.
Neurology|May 6, 2009
Bevacizumab and irinotecan for recurrent oligodendroglial tumorsS Taillibert, L A Vincent, B Granger, et al.
Pageof 10